Evidence map›Paper›PMID 40957475›Full record

ArticleEnvironmental research2025

Extremely low-frequency magnetic fields (ELF-MF) and radiofrequency: Risk of childhood CNS tumors in a city with elevated ELF-MF exposure.

Víctor Correa-Correa, Juan Carlos Núñez-Enríquez, Gabor Mezei, Roberto Rivera-Luna, José Gabriel Peñaloza-González, Salvador Daniel Rivas-Carrillo, Cuauhtémoc Gil Ortiz-Mejía, Claudia Flores-Robles, Erick Velasco-Ramírez, Mario Alexis Del Real-Gallegos and 26 more

Erratum issuedAbstract read
In one paragraph

Article in Environmental research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

36 authors.

Víctor Correa-CorreaDepartamento de Neurocirugía, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez," "CMN Siglo XXI," IMSS, Mexico City, Mexico.
Juan Carlos Núñez-EnríquezDivisión de Investigación en Salud, Unidad Médica de Alta Especialidad (UMAE), Hospital de Pediatría "Dr. Silvestre Frenk Freund", Centro Médico Nacional (CMN) "Siglo XXI," Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
Gabor MezeiHealth Sciences, Exponent, Inc., 474 14th Street, Suite 400, Oakland, CA, 94612, USA.
Roberto Rivera-LunaDepartamento de Oncología, INP, SS, Mexico City, Mexico.
José Gabriel Peñaloza-GonzálezDepartamento de Onco-Pediatría, Hospital Juárez de México, SS, Mexico City, Mexico.
Salvador Daniel Rivas-CarrilloLaboratorio de Genómica del Cancer, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico; Facultad de Medicina, Universidad Nacional Autónoma de México (UNAM), México City, Mexico.
Cuauhtémoc Gil Ortiz-MejíaDepartamento de Neurocirugía. Centro Medico Nacional 20 de Noviembre, ISSSTE, Mexico City, Mexico.
Claudia Flores-RoblesDepartamento de Neurocirugía pediátrica, Hospital General "Gaudencio González Garza" Centro Médico Nacional La Raza. Instituto Mexicano del Seguro Social (IMSS). Mexico City, Mexico.
Erick Velasco-RamírezDepartamento de Neurocirugía pediátrica, Hospital General "Gaudencio González Garza" Centro Médico Nacional La Raza. Instituto Mexicano del Seguro Social (IMSS). Mexico City, Mexico.
Mario Alexis Del Real-GallegosDepartamento de Neurocirugía pediátrica, Hospital General "Gaudencio González Garza" Centro Médico Nacional La Raza. Instituto Mexicano del Seguro Social (IMSS). Mexico City, Mexico.
Janet Flores-LujanoUnidad de Investigación Médica en Epidemiología Clínica, Unidad Médica de Alta Especialidad (UMAE), Hospital de Pediatría, Centro Médico Nacional (CMN) "Siglo XXI," Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
Fernanda Valeria Flores-PérezLaboratorio de Genómica del Cancer, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico; Ingeniería en Biotecnología. Instituto Tecnológico de Estudios Superiores Monterey (ITESM), Campus Ciudad de Mexico, Mexico City, Mexico.
Gerardo Sánchez-RodríguezDepartamento de Neurocirugía, UMAE Hospital de Pediatría, CMN "Siglo XXI," IMSS, Mexico City, Mexico.
Alma Griselda Ramírez-ReyesDepartamento de Neurocirugía, UMAE Hospital de Pediatría, CMN "Siglo XXI," IMSS, Mexico City, Mexico.
Enrique López-AguilarDepartamento de Oncología, UMAE Hospital de Pediatría, CMN "Siglo XXI," IMSS, Mexico City, Mexico.
David Aldebarán Duarte-RodríguezCoordinación de Investigación en Salud, Centro Medico Nacional Siglo XXI, IMSS, 06720 Mexico City, Mexico.
Susana Anaya-LópezDepartamento de Oncología pediátrica, Hospital General "Gaudencio González Garza" Centro Médico Nacional La Raza. Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
Maria Luisa Pérez-SaldívarUnidad de Investigación Médica en Epidemiología Clínica, Unidad Médica de Alta Especialidad (UMAE), Hospital de Pediatría, Centro Médico Nacional (CMN) "Siglo XXI," Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
Fernando Chico-Ponce-de-LeónDepartamento de Neurocirugía, Hospital Infantil de México Federico Gómez, Secretaria de Salud (SS), Mexico City, Mexico.
Silvia Jimenez-MoralesLaboratorio de Medicina de Precisión, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City, Mexico.
Vicente González-CarranzaDepartamento de Neurocirugía, Hospital Infantil de México Federico Gómez, Secretaria de Salud (SS), Mexico City, Mexico.
Minerva Mata-RochaCONACyT-Unidad de Investigacion Medica en Epidemiologia Clinica, Hospital de Pediatria, Centro Medico Nacional Siglo XXI, IMSS, 06720 Mexico City, Mexico; Unidad de Investigacion Medica en Genética Humana, Hospital de Pediatria, Centro Medico Nacional Siglo XXI, IMSS, 06720 Mexico City, Mexico.
Alfonso Marhx-BrachoDepartamento de Neurocirugía, INP, SS, Mexico City, Mexico.
Haydeé Rosas-VargasUnidad de Investigacion Medica en Genética Humana, Hospital de Pediatria, Centro Medico Nacional Siglo XXI, IMSS, 06720 Mexico City, Mexico.
Arturo Hermilo Godoy-EsquivelDepartamento de Cirugía Pediátrica, Hospital Pediátrico "Moctezuma," Secretaría de Salud de la Ciudad de México (SSCDMX), Mexico City, Mexico.
Jesús García-CortésDepartamento de Cirugía Pediátrica, Hospital Pediátrico "Coyoacán", Secretaría de Salud de la Ciudad de México (SSCDMX), Mexico City, Mexico.
Oscar Delgadillo-BonoDepartamento de Cirugía Pediátrica, Hospital Pediátrico "Tacubaya", Secretaría de Salud de la Ciudad de México (SSCDMX), Mexico City, Mexico.
Gregorio JaimesDepartamento de Cirugía Pediátrica, Hospital Pediátrico "Azcapotzalco", Secretaría de Salud de la Ciudad de México (SSCDMX), Mexico City, Mexico.
Joselyn Ramírez-MarroquínDepartamento de Cirugía Pediátrica, Hospital Pediátrico "La Villa", Secretaría de Salud de la Ciudad de México (SSCDMX), Mexico City, Mexico.
Patricia Flores-GaliciaDepartamento de Cirugía Pediátrica, Hospital Pediátrico "San Juan de Aragón", Secretaría de Salud de la Ciudad de México (SSCDMX), Mexico City, Mexico.
Claudia Contreras-FriasCoordinación de Educacion e Investigación en Salud, Hospital General Regional No 1 "Dr. Carlos Mac Gregor Sánchez Navarro," IMSS, Mexico City, Mexico.
Ures Eduardo Campos-RodríguezDepartamento de Neurocirugía, UMAE Hospital de Pediatría, CMN "Siglo XXI," IMSS, Mexico City, Mexico.
Eli Hernández-ChávezDepartamento de Neurocirugía, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez," "CMN Siglo XXI," IMSS, Mexico City, Mexico.
Jorge Meléndez-ZajglaLaboratorio de Genomica Funcional del Cancer, Instituto Nacional de Medicina Genomica (INMEGEN), Mexico City, Mexico.
Aurora Medina-SansonDepartamento de Hemato-Oncología, Hospital Infantil de México Federico Gómez, Secretaria de Salud (SS), Mexico City, Mexico. Electronic address: auroramedina@aol.com.mx.
Juan Manuel Mejía-AranguréLaboratorio de Genomica Funcional del Cancer, Instituto Nacional de Medicina Genomica (INMEGEN), Mexico City, Mexico. Electronic address: jmejia@inmegen.gob.mx.

Funding

Understanding the Increased Risk of Childhood Acute Lymphoblastic Leukemia in LatinosR01CA262263 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Adam De Smith · 2022 to 2026
$3.4M
Support For Infrastructure of Childhood Leukemia Environmental ResearchU24ES028524 · NIEHS · UNIVERSITY OF CALIFORNIA BERKELEY · PI METAYER, CATHERINE · 2023 to 2025
$1.1M
NCI NIH HHS R01 CA262263NIEHS NIH HHS U24 ES028524
6 · The paper itself

Abstract

backgroundCentral nervous system tumors (CNSTs) are the second most common childhood cancer. While their etiology is unclear, exposure to extremely low-frequency magnetic fields (ELF-MF) and radiofrequency (RF) may be associated with increased risk. This study aims to examine the relationship between ELF-MF and RF exposure and CNST risk in Mexico City's pediatric population.

methodsA case-control study was conducted in Mexico City (2017-2022), to assess ELF-MF and RF exposure in 200 CNST patients and 793 controls under 16 years old. Residential ELF-MF exposure was measured over 24 h, and RF exposure was assessed through the total duration of cell phone calls and electronic device usage (with and without internet). ELF-MF exposure levels below 0.1 μT and the lowest RF exposure quartile (Q1) served as reference groups for adjusted odds ratio (aOR) analyses. Data analysis was performed using R and SPSS software.

resultsOf all participants, 5.1 % had ELF-MF exposure ≥0.3 μT. Elevated ELF-MF exposure (≥0.4 μT) was significantly associated with an increased risk of CNST (aOR (95 % confidence interval) = 2.39 (1.15-5.00). While cell phone use showed no differences between cases and controls, prolonged tablet use (with and without internet) was significantly associated with increased CNST risk (aOR = 2.53 (1.39-4.61), and 3.53 (1.45-8.59), respectively).

conclusionA high proportion of children in Mexico City are exposed to ELF-MF levels ≥0.3 μT, exceeding levels reported in other populations. Elevated residential ELF-MF exposure, as well as prolonged tablet use, both with and without internet connectivity, were significantly associated with an increased risk of developing CNST in childhood.

Indexed as

Central Nervous System NeoplasmsElectromagnetic FieldsEnvironmental ExposureMagnetic FieldsRadio WavesAdolescentCase-Control StudiesChildChild, PreschoolCitiesFemaleHumansInfantMaleMexicoCancerCase–control studyChildrenEnvironmental factorsEtiology

Identifiers

PMID40957475
PMCPMC12799243

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.